{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:40Z","timestamp":1759405300242,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vaccine.2023.04.053","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T03:13:37Z","timestamp":1682478817000},"page":"5090-5096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-3337","authenticated-orcid":false,"given":"Xi","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasita","family":"Horlad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.053_b0005","unstructured":"WHO Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/ (accessed 31 October 2022)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0010","first-page":"9","article-title":"Acceptance of a COVID-19 vaccine in Japan during the COVID-19 pandemic","author":"Machida","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.04.053_b0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","article-title":"Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment","volume":"397","author":"Wouters","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.04.053_b0025","unstructured":"Pfizer-BioNTech COVID-19 vaccines. US Food and Drug Administration https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/pfizer-biontech-covid-19-vaccine (accessed 24 December 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0030","unstructured":"US Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine EUA letter of authorization. https:\/\/www.fda.gov\/media\/144412\/download; 2021 (accessed 24 Dec 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0035","unstructured":"US Food and Drug Administration. Spikevax and Moderna COVID-19 vaccine. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/moderna-covid-19-vaccine; 2022 (accessed 20 February 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel Coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0045","first-page":"1","article-title":"Injection fears and COVID-19 vaccine hesitancy","author":"Freeman","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0050","first-page":"9","article-title":"Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: A cross-sectional study from Poland","author":"Szmyd","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.04.053_b0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","article-title":"Vaccine hesitancy: the next challenge in the fight against COVID-19","volume":"35","author":"Dror","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.04.053_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211007393","article-title":"Considering needle phobia among adult patients during mass COVID-19 vaccinations","volume":"12","author":"Love","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.vaccine.2023.04.053_b0065","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1016\/j.vaccine.2015.04.040","article-title":"Strategies for addressing vaccine hesitancy - A systematic review","volume":"33","author":"Jarrett","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.053_b0070","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.04.053_b0075","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2023.04.053_b0080","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: A retrospective cross-sectional study","volume":"14","author":"El-Shitany","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0085","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0090","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/vaccines9101149","article-title":"Association between immunoglobulin G levels and adverse effects following vaccination with the BNT162b2 vaccine among Japanese healthcare workers","volume":"9","author":"Otani","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.04.053_b0095","unstructured":"COVID-19 Vaccine Awareness Guide. GovAe; 2021. https:\/\/www.dha.gov.ae\/Asset%20Library\/COVID19\/Covid19_Vaccine_EN.pdf (accessed 20 February 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0100","unstructured":"World Health Organization. Evidence Assessment: Sinopharm\/BBIBP COVID-19 vaccine. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2021\/april\/2_sage29apr2021_critical-evidence_sinopharm.pdf (accessed 20 February 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","article-title":"Sex differences in vaccine-induced humoral immunity","volume":"41","author":"Fischinger","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2023.04.053_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cophys.2018.03.010","article-title":"The evolution of greater humoral immunity in females than males: implications for vaccine efficacy","volume":"6","author":"Fink","year":"2018","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.vaccine.2023.04.053_b0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.053_b0120","first-page":"6","article-title":"Immune history and influenza vaccine effectiveness","author":"Lewnard","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.04.053_b0125","unstructured":"Ministry of Health, Labour and Welfare. Comprehensive Survey of Living Conditions; 2019. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-tyosa\/k-tyosa19\/dl\/04.pdf. (accessed 17 July 2020)."},{"key":"10.1016\/j.vaccine.2023.04.053_b0130","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.053_b0135","first-page":"752","article-title":"Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers","volume":"10","author":"Klugar","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.vaccine.2023.04.053_b0140","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","article-title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response","volume":"184","author":"Panda","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.04.053_b0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10935-021-00633-4","article-title":"Young adults underestimate how well peers adhere to COVID-19 preventive behavioral guidelines","volume":"42","author":"Graupensperger","year":"2021","journal-title":"J Prim Prev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:58Z","timestamp":1759404478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0264410X23004693"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and adverse effects of the coronavirus disease 2019 vaccine among the general Japanese adult population","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}